Long-Term Safety, Efficacy, and Adherence of Tralokinumab for the Treatment of Patients with moderate to severe atopic Dermatitis over a Period of up to 3 Years: Interim Analysis of ECZTEND, a Phase III Long-Term Extension Study - Wollenberg, Andreas; Blauvelt, Andrew; Lacour, Jean-Philippe; Toth, Darryl; Laquer, Vivian; Herranz, Pedro; Pink, Andrew; Peris, Ketty; Saeki, Hidehisa; Beissert, Stefan (JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022)